- Home
- AMS vs PMN Comparison
AMS vs PMN Comparison
Compare AMS & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- PMN
- Stock Information
- Founded
- AMS 1980
- PMN 2004
- Country
- AMS United States
- PMN Canada
- Employees
- AMS N/A
- PMN N/A
- Industry
- AMS Medical Specialities
- PMN Pharmaceuticals and Biotechnology
- Sector
- AMS Health Care
- PMN Health Care
- Exchange
- AMS Nasdaq
- PMN Nasdaq
- Market Cap
- AMS 19.3M
- PMN 18.8M
- IPO Year
- AMS N/A
- PMN N/A
- Fundamental
- Price
- AMS $2.73
- PMN $0.61
- Analyst Decision
- AMS
- PMN Strong Buy
- Analyst Count
- AMS 0
- PMN 1
- Target Price
- AMS N/A
- PMN $6.00
- AVG Volume (30 Days)
- AMS 17.4K
- PMN 37.4K
- Earning Date
- AMS 04-04-2025
- PMN 05-13-2025
- Dividend Yield
- AMS N/A
- PMN N/A
- EPS Growth
- AMS 243.96
- PMN N/A
- EPS
- AMS 0.33
- PMN 0.11
- Revenue
- AMS $28,340,000.00
- PMN N/A
- Revenue This Year
- AMS $13.15
- PMN N/A
- Revenue Next Year
- AMS N/A
- PMN N/A
- P/E Ratio
- AMS $8.12
- PMN $5.68
- Revenue Growth
- AMS 32.90
- PMN N/A
- 52 Week Low
- AMS $2.51
- PMN $0.51
- 52 Week High
- AMS $4.60
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- AMS 49.69
- PMN 48.35
- Support Level
- AMS $2.62
- PMN $0.51
- Resistance Level
- AMS $2.77
- PMN $0.65
- Average True Range (ATR)
- AMS 0.15
- PMN 0.08
- MACD
- AMS -0.00
- PMN 0.01
- Stochastic Oscillator
- AMS 53.06
- PMN 49.96
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.